NXS 0.00% 20.0¢ next science limited

re-read the december quarterly, page-5

  1. 707 Posts.
    lightbulb Created with Sketch. 10
    Dr Dann
    Just to inform, you are correct re Santos carrying out the repairs to fix the electrical fault last year however NXS did claim compensation from Santos circa $16m for lost sales/ profits and this amount appears in dispute (would greatly assist NXS in its current situation). I refer you to June 30/2013 accounts showing trade receivables of $22m circa however LT had been down and only produced $6m circa in that quarter, where is the $16m from?. I repeatedly asked NXS for clarity and finally received an answer (my HC post #9850885 4/11/13) stating that the receivables balance represented gas sales and GSA claim for remedies, no further comment due to confidentiality issues.
    There is a real difference this time regarding the staying power of NXS, on 14/1/13 when LT went down for 5 months, NXS had $95m in the bank (31/12) having just sold 2% Crux for $75m on 19/12, even with LT out they were very confident of an outcome because they repaid $60m debt in the March Qtr.
    The current situation (31/12) they have $4.8m cash + restricted cash $5.3m, proposed admin costs alone for this qtr are $4.8m, dev costs $1.8m and what the Dec Qtrly doesn't show is the Current Liabilities at 31/12, in effect the $4.8m is potentially not free cash.
    In the absence of LT rectification, longlead sales, Crux sale, Santos $!6m receipt, NXS doesn't have 2, 3 or 4 months up its sleeve like last time.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.